Abstract: Provided herein is a method for preparing a metal oxide nanoparticle/graphene composite using a supercritical fluid and the metal oxide nanoparticle/graphene composite prepared thereby, the method including preparing a dispersed solution by dispersing graphene oxide and a metal oxide precursor in an organic solvent and forming the metal oxide nanoparticle/graphene composite by reacting the dispersed solution under a supercritical condition, thereby uniformly dispersing the metal oxide nanoparticles on a graphene sheet.

Abstract: The present invention provides a GOA circuit structure for a slim-bezel LCD, including: a latch, a NAND gate, a buffer unit, and a reset unit. An input signal is supplied to the latch and an output signal is supplied from the buffer unit. The buffer unit includes a plurality of TFTs formed of a first metal layer (1), a second metal layer (2), and an active layer (3) arranged between the first metal layer (1) and the second metal layer (2). Each of the TFTs includes a dual-gate arrangement including a bottom gate formed of the first metal layer (1), a source and a drain formed of the second metal layer (2), and a top gate also formed of the second metal layer (2) so that the size of the TFT of the buffer unit can be reduced, the width of buffer unit can be reduced, thereby reducing the width of the GOA circuit and allowing a bezel of the LCD to be slimmer.

Abstract: The present invention provides a detection circuit of an In Cell type touch display panel and a detection method. By locating a line multiplexer corresponding to the touch sensing electrodes of each column, and selecting and charging at least one parasitic capacitor constructed with the touch sensing electrode and a ground in the touch sensing electrodes of the column with the line multiplexer, and then, measuring the charge electric quantity with the electric quantity measurement unit, and judging whether the touch sensing electrode faults or not according to the value of the charged electric quantity, the detection circuit can accomplish the fault detection to the touch sensing electrode in the array process.

Abstract: The present invention relates to a GOA circuit for tablet display and a display device. The GOA circuit comprises cascaded plurality of GOA units, the GOA unit comprises a pull-up control part 400 and a transfer part 500; the transfer part 500 comprises a first thin film transistor T22, the gate thereof is connected with the gate signal point Q(n), the drain and the source are respectively input the clock signal CK(n) and output the turn-on signal ST(n); the pull-up control part comprises: a second thin film transistor T11, the gate thereof is input the turn-on signal ST(n?2), the drain and the source are respectively connected with the horizontal scan line G(n?2) and the gate signal point Q(n); a third tin film transistor T12, the gate thereof is connected with the horizontal scan line G(n?1), the drain and the source are respectively connected with the horizontal scan line G(n?1) and the gate signal point Q(n). The present invention also provides a related display device.

Abstract: The present invention relates to a GOA circuit for tablet display and a display device. The GOA circuit comprises cascaded plurality of GOA units, the GOA unit comprises a pull-up control part 400 and a transfer part 500; the transfer part 500 comprises a first thin film transistor T22, the gate thereof is connected with the gate signal point Q(n), the drain and the source are respectively input the clock signal CK(n) and output the turn-on signal ST(n); the pull-up control part comprises: a second thin film transistor T11, the gate thereof is input the turn-on signal ST(n?2), the drain and the source are respectively connected with the horizontal scan line G(n?2) and the gate signal point Q(n); a third tin film transistor T12, the gate thereof is connected with the horizontal scan line G(n?1), the drain and the source are respectively connected with the horizontal scan line G(n?1) and the gate signal point Q(n). The present invention also provides a related display device.

Abstract: Provided herein is a method for preparing a metal oxide nanoparticle/graphene composite using a supercritical fluid and the metal oxide nanoparticle/graphene composite prepared thereby, the method including preparing a dispersed solution by dispersing graphene oxide and a metal oxide precursor in an organic solvent and forming the metal oxide nanoparticle/graphene composite by reacting the dispersed solution under a supercritical condition, thereby uniformly dispersing the metal oxide nanoparticles on a graphene sheet.

Abstract: Compounds having drug and bio-affecting properties, their pharmaceutical compositions and methods of use are set forth. In particular, diketopiperidine derivatives that possess unique antiviral activity are provided. These compounds are useful for the treatment of HIV and AIDS.

Abstract: Fused cyclic compounds, methods of using such compounds in the treatment of nuclear hormone receptor-associated conditions such as cancer and immune disorders, and pharmaceutical compositions containing such compounds.

Abstract: Compounds having drug and bio-affecting properties, their pharmaceutical compositions and methods of use are set forth. In particular, diketopiperidine derivatives that possess unique antiviral activity are provided. These compounds are useful for the treatment of HIV and AIDS.

Abstract: The present invention is directed to metabolites of ?N-(2-Chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide, the compound of formula (I), pharmaceutical compositions thereof, and to methods of using the metabolites and the pharmaceutical compositions in the treatment of oncological and immunological disorders.

Abstract: Fused cyclic compounds, methods of using such compounds in the treatment of nuclear hormone receptor-associated conditions such as cancer and immune disorders, and pharmaceutical compositions containing such compounds.

Abstract: Isolated nucleic acid and amino acid sequences for phenylalanine aminomutase enzyme and methods for purifying this enzyme are provided. Methods for altering biosynthesis of compounds in plant cell cultures are also provided. In particular, methods for altering production of taxanes and taxane-related compounds are provided.

Abstract: A microbial method for the preparation of an epothilone containing a terminal hydroxyalkyl group, comprising contacting at least one epothilone having a terminal alkyl group with an enzyme or microorganism capable of catalyzing the selective hydroxylation of said alkyl group to a hydroxyalkyl group, and effecting said hydroxylation.

Abstract: A microbial method for the preparation of an epothilone containing a terminal hydroxyalkyl group, comprising contacting at least one epothilone having a terminal alkyl group with an enzyme or microorganism capable of catalyzing the selective hydroxylation of said alkyl group to a hydroxyalkyl group, and effecting said hydroxylation.

Abstract: Fused cyclic compounds, methods of using such compounds in the treatment of nuclear hormone receptor-associated conditions such as cancer and immune disorders, and pharmaceutical compositions containing such compounds.

Abstract: Fused cyclic compounds, methods of using such compounds in the treatment of nuclear hormone receptor-associated conditions such as cancer and immune disorders, and pharmaceutical compositions containing such compounds.

Abstract: Macrocyclic isoquinoline peptides are disclosed having the general formula: A compound of formula I: wherein R1 to R9, Q and W are described in the description. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.

Abstract: Fused cyclic compounds, methods of using such compounds in the treatment of nuclear hormone receptor-associated conditions such as cancer and immune disorders, and pharmaceutical compositions containing such compounds.

Abstract: The present invention is directed to metabolites of ?N-(2-Chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide, the compound of formula (I), pharmaceutical compositions thereof, and to methods of using the metabolites and the pharmaceutical compositions in the treatment of oncological and immunological disorders.

Abstract: Novel non-steroidal compounds are provided which are glucocorticoid receptor modulators which are useful in treating diseases requiring glucocorticoid receptor agonist or antagonist therapy such as obesity, diabetes, inflammatory and immune disorders, and have the structure where Z is CONR1R2 or CH2NR1R2 and where R, Ra, Rb, Rc, Rd, Z, A and B are defined herein.